Healthcare IT attracts $956 million in Q3 of 2014

October 18, 2014 | Saturday | News | By BioSpectrum Bureau

Healthcare IT attracts $956 million in Q3 of 2014

There were 252 investors who participated this quarter including angels, VCs, Private Equity, and corporate VCs. The quarter also included 12 accelerators/incubators

There were 252 investors who participated this quarter including angels, VCs, Private Equity, and corporate VCs. The quarter also included 12 accelerators/incubators

Venture capital (VC) funding in the healthcare information technology came to $956 million, raised in 212 deals globally, a decline of 46 percent in terms of dollars compared to the massive $1.8 billion in 161 deals raised in Q2 2014, a rare quarter. However, Q3 2014 was still the second highest quarter for VC funding since 2010. Total VC funding year-to-date adds up to $3.6 billion. This was revealed in a report on funding and mergers and acquisitions (M&A) activity in the sector for the third quarter of 2014 by the Mercom Capital Group, a global communications and consulting firm. Mercom's comprehensive report covers deals of all sizes in Healthcare IT across the globe.

"Healthcare IT saw another big fundraising quarter in Q3 with almost a billion raised. Companies from countries outside of the United States, accounted for a record 21 percent share of the funding. While consumer-centric companies attracted the majority of the funding this quarter, M&A has been a different story with most (86 percent) of the deals involving practice-focused companies," commented Mr Raj Prabhu, CEO and co-founder of Mercom Capital Group.

Consumer-focused technologies received 65 percent of all VC investments in the third quarter of 2014, with $623 million in 140 deals compared to $678 million in 100 deals in Q2 2014. Areas that received the most funding under this category were Mobile Health with $345 million in 82 deals, followed by Telehealth, which had its best quarter, with $101 million in 16 deals, Personal Health with $85 million in 24 deals, Social Health with $70 million in three deals, and Scheduling, Rating & Shopping with $23 million in 15 deals.

Practice-centric companies received $333 million in 72 deals in the third quarter of 2014, compared to $1.1 billion in 61 deals in Q2. Under this category, the areas that received the most funding were Revenue Cycle Management with $75 million in eight deals, and Data Analytics with $71 million in 19 deals.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy